AVITA Medical Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 166/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.90.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
AVITA Medical Inc's Score
Industry at a Glance
Industry Ranking
166 / 404
Overall Ranking
293 / 4578
Industry
Biotechnology & Medical Research
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
6
analysts
Buy
Current Rating
6.900
Target Price
+100.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
AVITA Medical Inc Highlights
StrengthsRisks
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 86.66% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 64.25M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 64.25M.
Overvalued
The company’s latest PE is -1.90, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 7.68M shares, decreasing 20.68% quarter-over-quarter.
AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
Ticker SymbolRCEL
CompanyAVITA Medical Inc
CEOVance (Cary G)
Websitehttps://www.avitamedical.com/
FAQs
What is the current price of AVITA Medical Inc (RCEL)?
The current price of AVITA Medical Inc (RCEL) is 3.440.
What is the symbol of AVITA Medical Inc?
The ticker symbol of AVITA Medical Inc is RCEL.
What is the 52-week high of AVITA Medical Inc?
The 52-week high of AVITA Medical Inc is 14.160.
What is the 52-week low of AVITA Medical Inc?
The 52-week low of AVITA Medical Inc is 3.250.
What is the market capitalization of AVITA Medical Inc?
The market capitalization of AVITA Medical Inc is 524.48M.
What is the net income of AVITA Medical Inc?
The net income of AVITA Medical Inc is -61.84M.
Is AVITA Medical Inc (RCEL) currently rated as Buy, Hold, or Sell?
According to analysts, AVITA Medical Inc (RCEL) has an overall rating of Buy, with a price target of 6.900.
What is the Earnings Per Share (EPS TTM) of AVITA Medical Inc (RCEL)?
The Earnings Per Share (EPS TTM) of AVITA Medical Inc (RCEL) is -1.810.